The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis

Cytokine

Volumn 66, Issue 2, 2014, Pages 127-132

  Oliveira, Walker Nonato ^a,b   Ribeiro, Luís Eduardo ^a   Schrieffer, Albert ^a,b   Machado, Paulo ^a,b   Carvalho, Edgar M ^a,b   Bacellar, Olívia ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais INCT DT CNPq MCT   (Brazil)

Author keywords

Human american tegumentary leishmaniasis; Immunopathogenesis; Leishmania braziliensis; Regulatory cytokines

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 27; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; MUCOSAL LEISHMANIASIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SERODIAGNOSIS; SKIN LEISHMANIASIS;

LEISHMANIA BRAZILIENSIS;

HUMAN AMERICAN TEGUMENTARY LEISHMANIASIS; IMMUNOPATHOGENESIS; LEISHMANIA BRAZILIENSIS; REGULATORY CYTOKINES;

ADULT; CELLS, CULTURED; FEMALE; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKINS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LEUKOCYTES, MONONUCLEAR; MALE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894682535     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.12.016     Document Type: Article

References (41)

1. Carvalho E.M., Johnson W.D., Barreto E., Marsden P.D., Costa J.L., Reed S., et al. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol 1985, 135:4144-4148.
2. Scott P., Natovitz P., Coffman R.L., Pearce E., Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988, 168:1675-1684.
3. Bittencourt A.L., Barral A. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Memorias Inst Oswaldo Cruz 1991, 86:51-56.
4. Mendes D.S., Dantas M.L., Gomes J.M., dos Santos W.L., Silva A.Q., Guimaraes L.H., et al. Inflammation in disseminated lesions: an analysis of CD4+, CD20+, CD68+, CD31+ and vW+ cells in non-ulcerated lesions of disseminated leishmaniasis. Memorias Inst Oswaldo Cruz 2013, 108:18-22.
5. Ribeiro-de-Jesus A., Almeida R.P., Lessa H., Bacellar O., Carvalho E.M. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998, 31:143-148.
6. Bacellar O., Faria D., Nascimento M., Cardoso T.M., Gollob K.J., Dutra W.O., et al. Interleukin 17 production among patients with American cutaneous leishmaniasis. J Infect Dis 2009, 200:75-78.
7. Gonzalez-Lombana C., Gimblet C., Bacellar O., Oliveira W.W., Passos S., Carvalho L.P., et al. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog 2013, 9:e1003243.
8. Boaventura V.S., Santos C.S., Cardoso C.R., de Andrade J., Dos Santos W.L., Clarencio J., et al. Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur J Immunol 2010, 40:2830-2836.
9. Bacellar O., Lessa H., Schriefer A., Machado P., Ribeiro De Jesus A., Dutra W.O., et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002, 70:6734-6740.
10. Czarniecki C.W., Chiu H.H., Wong G.H., McCabe S.M., Palladino M.A. Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 1988, 140:4217-4223.
11. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 1988, 334:260-262.
12. Ding A., Nathan C.F., Graycar J., Derynck R., Stuehr D.J., Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol 1990, 145:940-944.
13. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
14. Yoshimura T., Takeda A., Hamano S., Miyazaki Y., Kinjyo I., Ishibashi T., et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 2006, 177:5377-5385.
15. Nadkarni S., Mauri C., Ehrenstein M.R. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 2007, 204:33-39.
16. Romero G.A. Predicting relapse after treatment for American cutaneous leishmaniasis. Bull World Health Organ 2001, 79:1169.
17. Machado P., Araujo C., Da Silva A.T., Almeida R.P., D'Oliveira A., Bittencourt A., et al. Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis 2002, 34:E69-73.
18. Lessa H.A., Machado P., Lima F., Cruz A.A., Bacellar O., Guerreiro J., et al. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 2001, 65:87-89.
19. Machado P.R., Lessa H., Lessa M., Guimaraes L.H., Bang H., Ho J.L., et al. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Clin Infect Dis 2007, 44:788-793.
20. Reed S.G., Badaro R., Masur H., Carvalho E.M., Lorenco R., Lisboa A., et al. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 1986, 35:79-85.
21. Villarino A., Hibbert L., Lieberman L., Wilson E., Mak T., Yoshida H., et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003, 19:645-655.
22. Artis D., Villarino A., Silverman M., He W., Thornton E.M., Mu S., et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J Immunol 2004, 173:5626-5634.
23. Murugaiyan G., Mittal A., Lopez-Diego R., Maier L.M., Anderson D.E., Weiner H.L. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 2009, 183:2435-2443.
24. Faria D.R., Gollob K.J., Barbosa J., Schriefer A., Machado P.R., Lessa H., et al. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 2005, 73:7853-7859.
25. Oliveira F., Bafica A., Rosato A.B., Favali C.B., Costa J.M., Cafe V., et al. Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg 2011, 85:70-73.
26. O'Garra A., Vieira P.L., Vieira P., Goldfeld A.E. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 2004, 114:1372-1378.
27. Carvalho E.M., Bacellar O., Barral A., Badaro R., Johnson W.D. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 1989, 83:860-864.
28. Carvalho E.M., Bacellar O., Brownell C., Regis T., Coffman R.L., Reed S.G. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994, 152:5949-5956.
29. Gautam S., Kumar R., Maurya R., Nylen S., Ansari N., Rai M., et al. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis 2011, 204:1134-1137.
30. Ding Y., Chen D., Tarcsafalvi A., Su R., Qin L., Bromberg J.S. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J Immunol 2003, 170:1383-1391.
31. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary mycobacterium bovis bacille calmette-Guerin infection. J Immunol 2007, 178:3786-3796.
32. Miyazaki Y., Hamano S., Wang S., Shimanoe Y., Iwakura Y., Yoshida H. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J Immunol 2010, 185:1150-1157.
33. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517.
34. Yoshimura A., Wakabayashi Y., Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem 2010, 147:781-792.
35. Cottrez F., Groux H. Regulation of TGF-beta response during T cell activation is modulated by IL-10. J Immunol 2001, 167:773-778.
36. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003, 170:4886-4890.
37. Findlay E.G., Greig R., Stumhofer J.S., Hafalla J.C., de Souza J.B., Saris C.J., et al. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J Immunol 2010, 185:2482-2492.
38. Freitas do Rosario A.P., Lamb T., Spence P., Stephens R., Lang A., Roers A., et al. IL-27 promotes IL-10 production by effect or Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol 2012, 188:1178-1190.
39. Giudice A., Vendrame C., Bezerra C., Carvalho L.P., Delavechia T., Carvalho E.M., et al. Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect Dis 2012, 12:75.
40. Cardoso L.S., Oliveira S.C., Goes A.M., Oliveira R.R., Pacifico L.G., Marinho F.V., et al. Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin Exp Immunol 2010, 160:266-274.
41. Faith A., Singh N., Farooque S., Dimeloe S., Richards D.F., Lu H., et al. T cells producing the anti-inflammatory cytokine IL-10 regulate allergen-specific Th2 responses in human airways. Allergy 2012, 67:1007-1013.